AMIDREX

This brand name is authorized in Nigeria.

Active ingredients

The drug AMIDREX contains one active pharmaceutical ingredient (API):

1	Risperidone UNII L6UH7ZF8HC - RISPERIDONE
	Risperidone is a selective monoaminergic antagonist with unique properties. Although risperidone is a potent D2 antagonist, which is considered to improve the positive symptoms of schizophrenia, it causes less depression of motor activity and induction of catalepsy than classical antipsychotics.
	Read more about Risperidone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-1676	Tablet	AMIDREX 2 TABLET TAB 2 mg 3x10	AMIDREX 2 TABLET RISPERIDONE USP 2 MG Risperidone USP 2 mg, Pre-gelatinized starch BP 20.08%, Microcrystalline cellulose BP 9.10%, Lactose BP 66.75%, Magnesium stearate 0.48%, Isopropyl alcohol 0.0365ml, Dicloromethane BP 0.0365ml A4-1676 Drugs Imported Products 3x10 Prescription Only Medicine (POM) 17/09/2021 GOLDMOORE INTERNATIONAL LIMITED, 56 Olorungbo Street, Anthony Village 18959076 goldmooreregulatory@gmail.com STALLION LABORATORIES PVT LTD, Plot No. C1B-305, 2,3,4,&5, G.I.D.C., Kerala Ahmedabad, Gujarat State, India., India	06/07/2023
A4-1677	Tablet	AMIDREX 1 TABLET TAB 1 mg 3x10	53 RNW-PP-213960 AMIDREX 1 TABLET RISPERIDONE USP 1MG Risperidone USP 1 mg, Pre-gelatinized starch BP 20.08%, Microcrystalline cellulose BP 9.10%, Lactose BP 66.75%, Magnesium stearate 0.48%, Colorway white 2.91%, Isopropyl alcohol 0.0365ml, Dicloromethane BP 0.0365ml A4-1677 Drugs Imported Products 3x10 Prescription Only Medicine (POM) 9/17/2021 GOLDMOORE INTERNATIONAL LIMITED, 56 Olorungbo Street, Anthony Village 18959076 goldmooreregulatory@gmail.com STALLION LABORATORIES PVT LTD, Plot No. C1B-305, 2,3,4,&5, G.I.D.C., Kerala Ahmedabad, Gujarat State, India., India	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AX08	Risperidone	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AX Other antipsychotics
Discover more medicines within N05AX08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-1676, A4-1677